Dr. Robin McKenzie

powered by
COS Expertise®
Johns Hopkins University
School of Medicine
Medicine
Infectious Diseases
Assistant ProfessorAppointed: 2000

Mailing Address

624 N. Broadway
Hampton House
Johns Hopkins University
Room 200
Baltimore, Maryland 21205
United States

Contact Information

Phone: (410) 502-3586
rmckenz@jhmi.edu

Keywords

COS Keywords:

Infectious Diseases Or Agents.

Additional Terms:

Infectious Diseases.

Languages

(Reading, Writing, Speaking)

French: (Basic, Basic, Basic)
Spanish: (Basic, Basic, Basic)

Memberships

Infectious Diseases Society of America

Publications

  • Taylor DN, McKenzie R, Durbin A, Carpenter C, Haake R, Bourgeois AL (Mar 2008) Systemic pharmacokinetics of rifaximin in volunteers with shigellosis., Antimicrobial agents and chemotherapy, 52 (3), 1179-81 Abstract
  • Glenn GM, Villar CP, Flyer DC, Bourgeois AL, McKenzie R, Lavker RM, Frech SA (May 2007) Safety and immunogenicity of an enterotoxigenic Escherichia coli vaccine patch containing heat-labile toxin: use of skin pretreatment to disrupt the stratum corneum., Infection and immunity, 75 (5), 2163-70 Abstract
  • McKenzie R, Bourgeois AL, Frech SA, Flyer DC, Bloom A, Kazempour K, Glenn GM (May 2007) Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): protective efficacy in a double-blind, placebo-controlled challenge study., Vaccine, 25 (18), 3684-91 Abstract
  • Carpenter CM, Hall ER, Randall R, McKenzie R, Cassels F, Diaz N, Thomas N, Bedford P, Darsley M, Gewert C, Howard C, Sack RB, Sack DA, Chang HS, Gomes G, Bourgeois AL (May 2006) Comparison of the antibody in lymphocyte supernatant (ALS) and ELISPOT assays for detection of mucosal immune responses to antigens of enterotoxigenic Escherichia coli in challenged and vaccinated volunteers., Vaccine, 24 (18), 3709-18 Abstract
  • Taylor DN, McKenzie R, Durbin A, Carpenter C, Atzinger CB, Haake R, Bourgeois AL (May 2006) Rifaximin, a nonabsorbed oral antibiotic, prevents shigellosis after experimental challenge., Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 42 (9), 1283-8 Abstract
  • McKenzie R, Bourgeois AL, Engstrom F, Hall E, Chang HS, Gomes JG, Kyle JL, Cassels F, Turner AK, Randall R, Darsley M, Lee C, Bedford P, Shimko J, Sack DA (Feb 2006) Comparative safety and immunogenicity of two attenuated enterotoxigenic Escherichia coli vaccine strains in healthy adults., Infection and immunity, 74 (2), 994-1000 Abstract
  • Kirkpatrick BD, McKenzie R, O'Neill JP, Larsson CJ, Bourgeois AL, Shimko J, Bentley M, Makin J, Chatfield S, Hindle Z, Fidler C, Robinson BE, Ventrone CH, Bansal N, Carpenter CM, Kutzko D, Hamlet S, LaPointe C, Taylor DN (Jan 2006) Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers., Vaccine, 24 (2), 116-23 Abstract
  • McKenzie R, Travel advice for HIV-infected individuals, The Hopkins Hiv Report : a Bimonthly Newsletter for Healthcare Providers / Johns Hopkins University Aids Service, 16(3), 9-12, May 2004
  • McKenzie R (May 2004) Travel advice for HIV-infected individuals., The Hopkins HIV report : a bimonthly newsletter for healthcare providers / Johns Hopkins University AIDS Service, 16 (3), 9-12 Abstract
  • McKenzie R, Reynolds JC, O'Fallon A, Dale J, Deloria M, Blackwelder W, Straus SE (Sep 2000) Decreased bone mineral density during low dose glucocorticoid administration in a randomized, placebo controlled trial, The Journal of Rheumatology, 27 (9), 2222-6
  • Marques AR, Lau DT, McKenzie R, Straus SE, Hoofnagle JH (Nov 1998) Combination therapy with famciclovir and interferon-alpha for the treatment of chronic hepatitis B, The Journal of Infectious Diseases, 178 (5), 1483-7
  • McKenzie R, O'Fallon A, Dale J, Demitrack M, Sharma G, Deloria M, Garcia-Borreguero D, Blackwelder W, Straus SE (Sep 1998) Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial, Jama : the Journal of the American Medical Association, 280 (12), 1061-6
  • Straus SE, Wald A, Kost RG, McKenzie R, Langenberg AG, Hohman P, Lekstrom J, Cox E, Nakamura M, Sekulovich R, Izu A, Dekker C, Corey L (Nov 1997) Immunotherapy of recurrent genital herpes with recombinant herpes simplex virus type 2 glycoproteins D and B: results of a placebo-controlled vaccine trial, The Journal of Infectious Diseases, 176 (5), 1129-34
  • McKenzie R, Straus SE (Jun 1996) Vaccine Therapy for Herpes Simplex Virus Infections: An Historical Perspective., Reviews in medical virology, 6 (2), 85-96 Abstract
  • McKenzie R, Straus SE (1996) Therapeutic immunization for recurrent herpes simplex virus infections, Advances in Experimental Medicine and Biology, 394, 67-83
  • McKenzie R, Fried MW, Sallie R, Conjeevaram H, Di Bisceglie AM, Park Y, Savarese B, Kleiner D, Tsokos M, Luciano C, Et Al. (Oct 1995) Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B, The New England Journal of Medicine, 333 (17), 1099-105
  • McKenzie R, Straus SE (1995) Chronic fatigue syndrome, Advances in Internal Medicine, 40, 119-53
  • McKenzie R, Kotwal GJ, Moss B, Hammer CH, Frank MM (Dec 1992) Regulation of complement activity by vaccinia virus complement-control protein, The Journal of Infectious Diseases, 166 (6), 1245-50
  • McKenzie R, Travis WD, Dolan SA, Pittaluga S, Feuerstein IM, Shelhamer J, Yarchoan R, Masur H (Sep 1991) The causes of death in patients with human immunodeficiency virus infection: a clinical and pathologic study with emphasis on the role of pulmonary diseases, Medicine, 70 (5), 326-43
  • Kotwal GJ, Isaacs SN, McKenzie R, Frank MM, Moss B (Nov 1990) Inhibition of the complement cascade by the major secretory protein of vaccinia virus, Science, 250 (4982), 827-30
  • Moreland LW, Corey J, McKenzie R (Feb 1988) Ludwig's angina. Report of a case and review of the literature, Archives of Internal Medicine, 148 (2), 461-6
  • McKenzie R, Reimer LG (Nov 1987) Effect of antimicrobials on blood cultures in endocarditis, Diagnostic Microbiology and Infectious Disease, 8 (3), 165-72
  • Smego RA Jr, McKenzie R, McManus RN (Feb 1987) Treatment of systemic nocardiosis, Lancet, 1 (8530), 456
  • Moreland LW, Brick JE, McKenzie R (Dec 1986) Temporal arteritis presenting with diplopia, The West Virginia Medical Journal, 82 (12), 481-2
  • McKenzie R, Khakoo R (May 1985) Blastomycosis of the esophagus presenting with gastrointestinal bleeding, Gastroenterology, 88 (5 Pt 1), 1271-3
  • McKenzie R (May 1985) Use of topical acyclovir in immunocompromised patients: is healing of lesions accelerated?, The Journal of Infectious Diseases, 151 (5), 670-1
  • Campbell IA, Middleton WG, McHardy GJ, Shotter MV, McKenzie R, Kay AB (Aug 1977) Interaction between isoprenaline and aminophylline in asthma, Thorax, 32 (4), 424-8
  • McKenzie R, Pepper DS, Kay AB (Jan 1975) The generation of chemotactic activity for human leukocytes by the action of plasmin on human fibrinogen, Thrombosis Research, 6 (1), 1-8
  • McKenzie R, Pepper DS, Kay AB (Dec 1974) Chromatographic and electrophoretic properties of synthetic human fibrinopeptides, Thrombosis Et Diathesis Haemorrhagica, 32 (2-3), 651-8
  • McKenzie R, Pepper DS, Kay AB (Dec 1974) Chromatographic and electrophoretic properties of synthetic human fibrinopeptides, Thrombosis Et Diathesis Haemorrhagica, 32 (2-3), 651-8

Profile Details

Last Verified: 3/30/2008

COS Expertise ID #1230043
Reference this profile directly: http://myprofile.cos.com/rmckenz